Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

Aymen I. Idris, R. J. van't Hof, Iain Robert Greig, Susan Ridge, D. Baker, Ruth Alexandra Ross, S. H. Ralston

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

Accelerated osteoclastic bone resorption has a central role in the pathogenesis of osteoporosis and other bone diseases. Identifying the molecular pathways that regulate osteoclast activity provides a key to understanding the causes of these diseases and to the development of new treatments. Here we show that mice with inactivation of cannabinoid type 1 (CB1) receptors have increased bone mass and are protected from ovariectomy-induced bone loss. Pharmacological antagonists of CB1 and CB2 receptors prevented ovariectomy-induced bone loss in vivo and caused osteoclast inhibition in vitro by promoting osteoclast apoptosis and inhibiting production of several osteoclast survival factors. These studies show that the CB1 receptor has a role in the regulation of bone mass and ovariectomy-induced bone loss and that CB1- and CB2-selective cannabinoid receptor antagonists are a new class of osteoclast inhibitors that may be of value in the treatment of osteoporosis and other bone diseases.
Original languageEnglish
Pages (from-to)774-779
Number of pages5
JournalNature Medicine
Volume11
Issue number7
DOIs
Publication statusPublished - Jul 2005

Keywords

  • nitric-oxide synthase
  • mice
  • inhibition
  • resorption
  • activation
  • diseases

Cite this

Idris, A. I., van't Hof, R. J., Greig, I. R., Ridge, S., Baker, D., Ross, R. A., & Ralston, S. H. (2005). Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nature Medicine, 11(7), 774-779. https://doi.org/10.1038/nm1255

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. / Idris, Aymen I.; van't Hof, R. J.; Greig, Iain Robert; Ridge, Susan; Baker, D.; Ross, Ruth Alexandra; Ralston, S. H.

In: Nature Medicine, Vol. 11, No. 7, 07.2005, p. 774-779.

Research output: Contribution to journalArticle

Idris, AI, van't Hof, RJ, Greig, IR, Ridge, S, Baker, D, Ross, RA & Ralston, SH 2005, 'Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors', Nature Medicine, vol. 11, no. 7, pp. 774-779. https://doi.org/10.1038/nm1255
Idris, Aymen I. ; van't Hof, R. J. ; Greig, Iain Robert ; Ridge, Susan ; Baker, D. ; Ross, Ruth Alexandra ; Ralston, S. H. / Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. In: Nature Medicine. 2005 ; Vol. 11, No. 7. pp. 774-779.
@article{32d0c70c898c471d9230ca67c3f9c208,
title = "Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors",
abstract = "Accelerated osteoclastic bone resorption has a central role in the pathogenesis of osteoporosis and other bone diseases. Identifying the molecular pathways that regulate osteoclast activity provides a key to understanding the causes of these diseases and to the development of new treatments. Here we show that mice with inactivation of cannabinoid type 1 (CB1) receptors have increased bone mass and are protected from ovariectomy-induced bone loss. Pharmacological antagonists of CB1 and CB2 receptors prevented ovariectomy-induced bone loss in vivo and caused osteoclast inhibition in vitro by promoting osteoclast apoptosis and inhibiting production of several osteoclast survival factors. These studies show that the CB1 receptor has a role in the regulation of bone mass and ovariectomy-induced bone loss and that CB1- and CB2-selective cannabinoid receptor antagonists are a new class of osteoclast inhibitors that may be of value in the treatment of osteoporosis and other bone diseases.",
keywords = "nitric-oxide synthase, mice, inhibition, resorption, activation, diseases",
author = "Idris, {Aymen I.} and {van't Hof}, {R. J.} and Greig, {Iain Robert} and Susan Ridge and D. Baker and Ross, {Ruth Alexandra} and Ralston, {S. H.}",
year = "2005",
month = "7",
doi = "10.1038/nm1255",
language = "English",
volume = "11",
pages = "774--779",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

AU - Idris, Aymen I.

AU - van't Hof, R. J.

AU - Greig, Iain Robert

AU - Ridge, Susan

AU - Baker, D.

AU - Ross, Ruth Alexandra

AU - Ralston, S. H.

PY - 2005/7

Y1 - 2005/7

N2 - Accelerated osteoclastic bone resorption has a central role in the pathogenesis of osteoporosis and other bone diseases. Identifying the molecular pathways that regulate osteoclast activity provides a key to understanding the causes of these diseases and to the development of new treatments. Here we show that mice with inactivation of cannabinoid type 1 (CB1) receptors have increased bone mass and are protected from ovariectomy-induced bone loss. Pharmacological antagonists of CB1 and CB2 receptors prevented ovariectomy-induced bone loss in vivo and caused osteoclast inhibition in vitro by promoting osteoclast apoptosis and inhibiting production of several osteoclast survival factors. These studies show that the CB1 receptor has a role in the regulation of bone mass and ovariectomy-induced bone loss and that CB1- and CB2-selective cannabinoid receptor antagonists are a new class of osteoclast inhibitors that may be of value in the treatment of osteoporosis and other bone diseases.

AB - Accelerated osteoclastic bone resorption has a central role in the pathogenesis of osteoporosis and other bone diseases. Identifying the molecular pathways that regulate osteoclast activity provides a key to understanding the causes of these diseases and to the development of new treatments. Here we show that mice with inactivation of cannabinoid type 1 (CB1) receptors have increased bone mass and are protected from ovariectomy-induced bone loss. Pharmacological antagonists of CB1 and CB2 receptors prevented ovariectomy-induced bone loss in vivo and caused osteoclast inhibition in vitro by promoting osteoclast apoptosis and inhibiting production of several osteoclast survival factors. These studies show that the CB1 receptor has a role in the regulation of bone mass and ovariectomy-induced bone loss and that CB1- and CB2-selective cannabinoid receptor antagonists are a new class of osteoclast inhibitors that may be of value in the treatment of osteoporosis and other bone diseases.

KW - nitric-oxide synthase

KW - mice

KW - inhibition

KW - resorption

KW - activation

KW - diseases

U2 - 10.1038/nm1255

DO - 10.1038/nm1255

M3 - Article

VL - 11

SP - 774

EP - 779

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 7

ER -